The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: a systematic review and meta ‐analysis
ConclusionThe mTOR inhibitor-based regimen is an attractive alternative with lower risk of CMV and BKPyV infections in kidney transplant recipients. The combination regimen is more appropriate and acceptable than the mTOR inhibitor monotherapy-based regimen. Early introduction of mTOR inhibitors is recommended, although it is worth noting that attention should be paid to wound healing when mTOR inhibitors are introduced early.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Chen Ye,
Jingjie Li,
Xiaoman Liu,
Jiajia Yan,
Jie Chen,
Changxi Wang,
Min Huang,
Xiao Chen,
Kejing Tang,
Pan Chen Tags: REVIEW Source Type: research
More News: Anemia | Cytomegalovirus | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Kidney Transplant | Kidney Transplantation | Study | Transplant Surgery | Transplants | Urology & Nephrology